These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6803390)

  • 1. Immunologic studies of factor VIII coagulant activity (VIII:C). 2. Factor VIII in selected vertebrates.
    Rotblat F; Hawkey C; O'Brien DP; Tuddenham EG
    Thromb Res; 1982 Mar; 25(5):423-31. PubMed ID: 6803390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varied immunological reactivity of factor VIII from animal plasmas.
    Coppola R; Lombardi R; Hawkey C; Ruggeri ZM; Mannucci PM
    Thromb Res; 1980 Feb 1-15; 17(3-4):473-80. PubMed ID: 6768162
    [No Abstract]   [Full Text] [Related]  

  • 3. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The separation of Willebrand factor from factor VIII-related antigen.
    Barrow ES; Reisner HM; Graham JB
    Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasma.
    Amrani DL; Mosesson MW; Hoyer LW
    Blood; 1982 Mar; 59(3):657-63. PubMed ID: 6800421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the stability of factor VIII coagulant antigen (VIII:CAg) in the presence of VIII:C antibodies.
    Furlong RA; Peake IR
    Br J Haematol; 1983 Jan; 53(1):55-63. PubMed ID: 6401211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of factor VIII coagulant antigen by proteolytic enzymes.
    Rick ME; Popovsky MA; Krizek DM
    Br J Haematol; 1985 Nov; 61(3):477-86. PubMed ID: 2933056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
    Tran TH; Lämmle B; Duckert F
    Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Von Willebrand's syndrome (author's transl)].
    Larrieu MJ; Meyer D; Ardaillou N
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):371-82. PubMed ID: 303357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of anamnestic response after transfusion of washed red blood cells in haemophilia A patients with antibody to factor VIII.
    Laurian Y; Girma JP; Allain JP; Verroust F; Larrieu MJ
    Scand J Haematol; 1982 Mar; 28(3):233-7. PubMed ID: 6806896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen.
    Benson RE; Johnson GS; Dodds WJ
    Br J Haematol; 1981 Dec; 49(4):541-50. PubMed ID: 6797460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
    Tran TH; Duckert F
    Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.
    Nachman R; Levine R; Jaffe EA
    J Clin Invest; 1977 Oct; 60(4):914-21. PubMed ID: 70434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzyme immunoassay (ELISA) for the quantitation of human factor VIII coagulant antigen (VIII:CAg).
    Dinesen B; Feddersen C
    Thromb Res; 1983 Sep; 31(5):707-18. PubMed ID: 6417826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological evidence that human factor VIII is composed of two linked moieties.
    Koutts J; Lavergne JM; Meyer D
    Br J Haematol; 1977 Nov; 37(3):415-28. PubMed ID: 341960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of factor VIII antigen by means of a simple slide test.
    Casonato A; Fabris F; Vicariotto M; Girolami A
    Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.